Abstract # 2945 Dosimetric Comparison of Cesium-131 and Palladium-103 for Permanent Prostate Brachytherapy

Presenter: Musmacher, Jeffrey

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

About the Presenter:
Mr. Jeffrey S. Musmacher, B.S.R.T. (T) is an Administrator in Radiation Oncology. Mr. Musmacher is the president of Oncology Professionals Management, Inc., a consulting firm in New York that provides remote treatment planning, physics QA services and clinical consulting. He was instrumental in developing the prostate brachytherapy and skin High Dose Rate (HDR) Brachytherapy program at multiple facilities. He has published and lectured on many topics including skin cancer, prostate brachytherapy and endorectal brachytherapy. Mr. Musmacher is an active professional member of the Society for Radiation Oncology Administrators, American Registry of Radiologic Technologists, and the American Society of Radiologic Technologists.
Contact the presenter at: jmusmacher@hunthosp.org

J. S. Musmacher*, R. T. Byrnes*, M. Ghaly*, K. Satchwill*, L. Rumpf*. , North Shore Medical Accelerator, Smithtown, NY,

Author Disclosure:
  J.S. Musmacher, Isoray, F. Consultant/Advisory Board; R.T. Byrnes, None; M. Ghaly, None; K. Satchwill, None; L. Rumpf, None.

Click on images to enlarge (a new pop-up window will open)

Dosimetric Comparison of Cesium-131 and Palladium-103 in Permanent Prostate Brachytherapy:

E-mail a friend about this abstract:
Enter email address: